XRN4 Antibody

What is XRN4 and why is it important for plant molecular biology research?

XRN4 is a cytoplasmic 5′→3′ exoribonuclease in plants that catalyzes the degradation of uncapped mRNAs from the 5′ end. It is the functional homolog of yeast and mammalian XRN1 and ortholog of the nuclear XRN2/RAT1 . XRN4 plays critical roles in:

• Modulation of the plant circadian clock, with mutations causing long period phenotypes

• Ethylene signaling (also known as ETHYLENE-INSENSITIVE5 or EIN5)

• Post-transcriptional regulation via mRNA decay pathways

• Dark and nitrogen stress responses

• Cotranslational mRNA decay (CTRD) associated with ribosomes

Understanding XRN4 function is essential for research on RNA metabolism, hormone signaling, and stress responses in plants.

What are the specifications of commercially available XRN4 antibodies?

Based on available data, XRN4 antibodies typically have the following specifications:

These antibodies are specifically designed for research applications and are not intended for diagnostic or therapeutic purposes .

How should XRN4 antibodies be used to detect association with ribosomes in polysome fractionation experiments?

To detect XRN4 association with ribosomes:

• Prepare plant tissue (shoot and/or root) from appropriate developmental stages

• Fractionate tissues using sucrose gradient centrifugation to separate free mRNPs from ribosome-bound fractions

• Collect and pool fractions corresponding to monosomes and polysomes (labeled as "Ribosome-bound fractions")

• Prepare separate pools containing free mRNPs

• Prepare an input sample prior to fractionation as a reference control

• Perform western blot analysis using XRN4-specific antibodies

• Compare XRN4 signal intensity between ribosome-bound fractions and free mRNPs relative to the input

This approach has revealed that XRN4 association with ribosomes varies significantly during development, with lower levels in 3-day-old seedlings, peaking at 15 days, and maintaining similar levels through 25 days .

What controls should be included when using XRN4 antibodies in western blot experiments?

For rigorous experimental design, include these controls:

• Positive control: Wild-type plant tissue known to express XRN4

• Negative control: xrn4 mutant tissue (e.g., xrn4-5) to confirm antibody specificity

• Loading control: Housekeeping protein like UGPase (use commercial antibody at 1/5000 dilution)

• Fractionation controls: When performing polysome analyses, include controls such as:

  • eIF-4A mRNA (specific to polyA+ fraction)

  • AT7SL ncRNA (specific to polyA- fraction)

• XRN4 variant controls: When available, include XRN4 functional variants like XRN4ΔCTRD or XRN4-GFP to assess specific functional domains

Recommended antibody dilution for XRN4 detection is 1/1000, with overnight incubation at 4°C under constant agitation .

How can XRN4 antibodies be used to study developmental regulation of cotranslational decay?

To investigate developmental regulation of cotranslational decay:

• Collect plant tissues at multiple developmental timepoints (e.g., 3, 15, and 25 days after germination)

• Perform polysome fractionation for each timepoint

• Run western blots on equal amounts of input and polysomal fractions using XRN4-specific antibodies

• Quantify XRN4 signals using appropriate software (e.g., Vilber) across at least 4 biological replicates

• Normalize polysomal XRN4 levels to input XRN4 levels

• Prepare and immunoblot all samples in parallel and expose simultaneously for accurate chemiluminescence quantification

Research has shown that XRN4 association with polysomes (indicating cotranslational decay activity) is developmentally regulated, with the enzyme progressively accumulating in polysomes during seedling development .

How should researchers interpret differences between XRN4 targets in polyA+ versus polyA- RNA fractions?

When analyzing XRN4 targets across RNA fractions:

• Compare differential expression patterns between wild-type and xrn4 mutants in both polyA+ and polyA- fractions separately

• Note that xrn4 mutants overaccumulate many more decapped deadenylated intermediates (polyA-) than polyadenylated (polyA+) transcripts

• Validate selected targets using northern blot analysis with fractionated RNA samples

• Include controls such as eIF-4A (polyadenylated) and AT7SL (non-polyadenylated) to confirm fractionation quality

• Recognize that transcripts may show increases in only polyA-, only polyA+, or both fractions in xrn4 mutants

What approaches are recommended for identifying genuine XRN4 substrates in degradome analyses?

For robust identification of XRN4 substrates from degradome data:

• Look specifically for transcripts with 5' ends precisely at cap sites, which represent decapped but undegraded intermediates

• Focus on transcripts showing significant accumulation in xrn4 mutants compared to wild-type

• Categorize substrates based on their enrichment in functional pathways (e.g., photosynthesis, nitrogen responses, auxin responses)

• Consider both transcriptional (DEGs) and post-transcriptional (DPGs) regulation

• Validate candidates using techniques such as cordycepin-induced transcriptional arrest followed by qRT-PCR

Research has shown that many XRN4 substrates are regulated at both transcriptional and post-transcriptional levels, with more differentially post-transcriptionally regulated genes (DPGs) than differentially expressed genes (DEGs) .

How do researchers determine if phenotypic changes in xrn4 mutants are linked to specific RNA targets?

To connect phenotypes to specific RNA targets:

• Perform RNA-seq and degradome analysis on wild-type and xrn4 mutants under conditions where phenotypic differences are observed

• Identify transcripts that:

  • Show altered abundance or stability in xrn4 mutants

  • Are associated with relevant biological functions based on GO enrichment

  • Have 5' ends precisely at cap sites (indicating direct XRN4 substrates)

• Validate candidates by measuring their half-lives after transcriptional inhibition using cordycepin

• Examine whether overexpression of specific target genes phenocopies the xrn4 mutant

• Assess the mutant phenotype under specific conditions (e.g., dark stress, nitrogen resupply)

Research has demonstrated that xrn4 mutants show defects in dark stress response and lateral root growth during nitrogen resupply, correlating with accumulation of specific mRNA targets related to these processes .

How can researchers distinguish between cotranslational and cytosolic XRN4-mediated decay?

To differentiate between these decay pathways:

• Generate and use XRN4ΔCTRD transgenic lines, which specifically lack the C-terminal region that enables cotranslational decay while preserving cytosolic function

• Compare transcript profiles between:

  • Wild-type plants

  • xrn4 null mutants (defective in both pathways)

  • XRN4ΔCTRD plants (defective in cotranslational decay only)

• Perform 5'Pseq assays to monitor read accumulation around stop and start codons

• Create meta-transcript plots comparing read distributions between genotypes

• Calculate Transcript Stability Index (TSI) values for each transcript across genotypes

This approach has revealed that in Arabidopsis shoots, 32% of XRN4 targets are only affected in xrn4 null mutants (cytosolic decay), 50% are exclusively targeted by CTRD, and 18% are regulated by both pathways .

What is the relationship between XRN4 function and circadian rhythm regulation?

The relationship between XRN4 and circadian rhythms involves:

This suggests XRN4 regulates circadian rhythms through post-transcriptional control of auxiliary clock factors rather than direct effects on core clock genes .

How does PAP (3'-phosphoadenosine 5'-phosphate) inhibit XRN4-mediated cotranslational decay?

PAP inhibition of XRN4 cotranslational decay involves:

• Ribosome association: PAP treatment reduces XRN4 accumulation in polysomes without affecting total XRN4 levels

• mRNA stabilization: Exogenous PAP treatment significantly increases the half-lives of CTRD target transcripts

  • Example data for At2g21350 transcript:

    • Shoot: 20.8 min (control) → 141.5 min (PAP treatment)

    • Root: 24.1 min (control) → 188.6 min (PAP treatment)

  • Example data for At1g66300 transcript:

    • Shoot: 17.2 min (control) → 58.1 min (PAP treatment)

    • Root: 25.7 min (control) → 58.8 min (PAP treatment)

• fry1 mutant effects: FRY1 mutants (which accumulate PAP) show stronger repression of CTRD than xrn4 mutants

• Target overlap: Strong overlap between XRN4 and FRY1 CTRD targets:

  • Shoot: 5,571 common targets (89% of FRY1 and 91% of XRN4 targets)

  • Root: 4,403 common targets (85.6% of FRY1 and 86.7% of XRN4 targets)

These findings suggest PAP acts as a regulatory molecule controlling XRN4-mediated cotranslational decay activity, potentially affecting multiple enzymes involved in the CTRD pathway .

What methodological approaches can determine whether a transcript is directly degraded by XRN4 versus indirectly affected?

To distinguish direct from indirect XRN4 targets:

• RNA degradome analysis:

  • Compare 5' end profiles between wild-type and xrn4 mutants

  • Direct targets show accumulation of reads with 5' ends precisely at cap sites in xrn4 mutants

  • Categorize transcripts based on their 5' end signature patterns

• Half-life measurements:

  • Treat plants with cordycepin to inhibit transcription

  • Collect tissue at multiple timepoints and measure transcript abundance

  • Compare decay rates between wild-type and xrn4 mutants

  • Direct targets show significantly extended half-lives in mutants

• Polysome association analysis:

  • Fractionate polysomes and isolate ribosome-bound and free mRNP fractions

  • Compare transcript abundance in these fractions between genotypes

  • Calculate Transcript Stability Index (TSI) values (>3 indicates CTRD targets)

• Genetic complementation tests:

  • Express XRN4 variants with specific mutations affecting catalytic activity

  • Assess which transcripts are rescued by different variants

• RNA fractionation:

  • Separate polyA+ and polyA- RNA populations

  • Compare accumulation patterns in both fractions

  • Direct XRN4 targets often accumulate significantly in the polyA- fraction

How can researchers investigate organ-specific differences in XRN4 function?

To study organ-specific XRN4 functions:

• Separate tissue collection:

  • Isolate shoot and root tissues independently from the same plants

  • Process samples in parallel under identical conditions for direct comparison

• Polysome profiling:

  • Perform polysome fractionation on both tissues

  • Compare XRN4 association with ribosomes between organs using western blot

  • Quantify differences in the distribution between free mRNPs and ribosome-bound fractions

• Transcriptome analysis:

  • Conduct RNA-seq on both organs from wild-type and xrn4 mutants

  • Identify organ-specific DEGs and DPGs

  • Perform Gene Ontology enrichment on organ-specific targets

• Target classification:

  • In shoots: CTRD is the major 5'-3' mRNA decay pathway

  • In roots: More complex pattern with most transcripts (61%) showing faster decay in xrn4 mutants

• Half-life measurements:

  • Perform cordycepin treatments on separated tissues

  • Compare mRNA stability of candidate transcripts between organs

  • Analyze differences in response to treatments like PAP between shoot and root

This approach has revealed significant organ-specific differences in XRN4 function, with cotranslational decay playing a more dominant role in shoots compared to roots .

How can researchers use XRN4 antibodies to investigate the relationship between mRNA decay and translation?

To investigate decay-translation relationships:

• Ribosome footprinting combined with XRN4 immunoprecipitation:

  • Perform ribosome profiling on wild-type and xrn4 mutants

  • Correlate ribosome occupancy with mRNA decay rates

  • Identify transcripts undergoing co-translational decay

• Polysome gradient analysis with XRN4 detection:

  • Fractionate polysomes into different densities (monosomes to heavy polysomes)

  • Perform western blots to detect XRN4 across fractions

  • Determine if XRN4 preferentially associates with specific ribosome populations

• Mechanistic studies:

  • Investigate how mutations in XRN4's C-terminal region (CTRD) affect ribosome association

  • Assess whether ribosome-associated quality control factors interact with XRN4

  • Determine how translation inhibitors affect XRN4 localization and activity

Research has shown that polyA+ mRNA targets of XRN4 are subject to co-translational decay, which modulates their translation efficiency during plant development .

What approaches can determine the mechanisms by which XRN4 selects specific mRNA targets?

To understand XRN4 target selection mechanisms:

• Sequence motif analysis:

  • Analyze 5' UTRs, coding regions, and 3' UTRs of XRN4 targets

  • Identify enriched sequence motifs or structural elements

  • Compare motifs between different classes of targets (CTRD vs. cytosolic decay)

• RNA structure predictions:

  • Perform in silico RNA structure predictions for target transcripts

  • Identify common structural elements that might influence XRN4 recognition

  • Validate through mutagenesis of predicted structures

• RNA-binding protein interactions:

  • Identify proteins that interact with both XRN4 and specific mRNAs

  • Investigate whether these proteins act as adapters for XRN4 targeting

  • Examples include BBX family proteins, which show stabilization in xrn4 mutants

• Comparative analysis across conditions:

  • Compare XRN4 targets across different developmental stages or stress conditions

  • Determine whether target selection is condition-dependent

  • Correlate with changes in XRN4 interaction partners

How can researchers investigate the interplay between XRN4 and nonsense-mediated decay (NMD)?

To study XRN4-NMD interactions:

• Double mutant analysis:

  • Generate double mutants between xrn4 and NMD components (UPF1, UPF2, UPF3)

  • Compare transcriptome profiles of single and double mutants

  • Identify synergistic or antagonistic effects on specific transcripts

• 3' fragment detection:

  • Monitor accumulation of 3' fragments of NMD targets in xrn4 mutants

  • Characterize cleavage sites to understand the mechanism of NMD in plants

  • Compare with systems containing the SMG6 endoribonuclease (absent in plants)

• Coupled decay pathway analysis:

  • Investigate whether XRN4 and NMD components co-localize in processing bodies

  • Determine if XRN4 physically interacts with NMD factors

  • Assess whether PAP affects NMD efficiency

Research has shown that xrn4 mutants accumulate 3' fragments of select NMD targets, despite plants lacking the metazoan endoribonuclease SMG6, suggesting XRN4 contributes to NMD through an alternative mechanism .